Klow (GHK-Cu / TB-500 / BPC-157 / KPV)

Klow is a multi-peptide blend prepared for laboratory research and professional reference use that combines four sequences each studied individually in the scientific literature: GHK-Cu (a copper-binding tripeptide), TB-500 (a synthetic fragment corresponding to the active region of Thymosin Beta-4), BPC-157 (a stable gastric pentadecapeptide derivative), and KPV (a tripeptide fragment associated with the alpha-melanocyte-stimulating hormone family). Categorized within the Healing and Recovery reference grouping, the blend is offered to licensed practitioners as a single combined catalog item that brings together sequences each examined in the preclinical literature in connection with tissue dynamics, cellular signaling, and the modulation of inflammatory pathways. This compound is not approved by the FDA for therapeutic use and is supplied strictly for laboratory research and professional reference purposes. It is not intended for the diagnosis, treatment, cure, or prevention of any condition, and individual results vary in any research context.

• Investigated in preclinical literature in connection with tissue remodeling and extracellular matrix dynamics
• Studied in research models for modulation of inflammatory signaling pathways
• Examined in experimental settings in relation to cellular migration and angiogenesis-associated activity
• Referenced in laboratory research exploring recovery- and repair-associated biological processes
• Explored in the scientific literature for the combined and overlapping signaling characteristics of its constituent peptides

For research handling reference only: the lyophilized peptide blend is typically reconstituted with bacteriostatic or sterile water added slowly against the vial wall and swirled gently rather than shaken until fully dissolved. Unreconstituted vials are generally stored frozen or refrigerated and kept sealed; once reconstituted, material is commonly kept refrigerated, protected from light, and handled under aseptic conditions to help preserve integrity. Repeated freeze-thaw cycles and exposure to heat or direct light are generally avoided. All clinical protocols, including any preparation concentrations, dosing, and administration decisions, are determined solely by the licensed ordering provider at their professional discretion; this is reference information only and is not medical advice.

A per-lot Certificate of Analysis, HPLC purity profile, and mass-spectrometry verification are available on request for this product. Ask your account manager for the current lot documentation.

The proposed mechanisms described in the research literature are distinct for each constituent and are thought to overlap when the sequences are combined. GHK-Cu has been studied as a copper-binding tripeptide reported to influence gene expression related to extracellular matrix turnover and antioxidant signaling; TB-500, as a Thymosin Beta-4-derived fragment, has been investigated in relation to actin sequestration and a proposed role in cell migration and angiogenesis; BPC-157 has been examined in preclinical models for reported effects on growth factor expression, nitric oxide pathways, and endothelial signaling; and KPV has been studied as an alpha-MSH-related fragment in connection with reported anti-inflammatory activity, potentially involving NF-kB pathway modulation. The combined behavior of these sequences in any research context remains an area of ongoing investigation, and individual results vary.